Skip to main content

21 Cfr Part 820 Toolkit

USD277.61
Availability:
Downloadable Resources, Instant Access
Adding to cart… The item has been added

What does the 21 CFR Part 820 Toolkit include?

The 21 CFR Part 820 Toolkit includes a complete digital playbook with approximately 60 files: 30-40 editable Excel spreadsheets (including a self-assessment dashboard, maturity trackers, and KPI dashboards), 20-30 PDF guides (including a 127-page self-assessment book, implementation playbooks, and policy templates), and 18 customisable Word documents covering DHF, DMR, DHR, and CAPA procedures. The package also features a 00_Platinum_Tier suite with a 90-day roadmap, incident response runbook, and observability dashboard, delivered by email within 24 business hours of purchase.

Are you risking FDA warning letters, product recalls, or delayed 510(k) clearances because your medical device quality system lacks full alignment with 21 CFR Part 820? Without a structured, audit-ready framework, organisations face heightened scrutiny, regulatory enforcement actions, and lost market opportunities. The 21 CFR Part 820 Toolkit delivers a complete, professionally structured digital playbook ensuring your team implements and sustains compliance with FDA’s Quality System Regulation and ISO 13485, eliminating gaps, accelerating audits, and turning regulatory requirements into operational advantage.

What You Receive

  • A 127-page editable PDF 21 CFR Part 820 Self-Assessment Book with 49 requirement-specific questions mapped to the RDMAICS improvement cycle (Recognise, Define, Measure, Analyse, Improve, Control, Sustain), enabling rapid gap identification and leadership alignment
  • An interactive Excel Self-Assessment Dashboard (XLSX) with pre-filled scoring logic that automatically calculates compliance maturity across all 21 CFR Part 820 subparts, generating visual reports for internal review and regulatory presentations
  • 999 evidence-based assessment questions categorised across seven core medical device domains: Design Controls, Corrective and Preventive Action (CAPA), Document Controls, Production and Process Controls, Management Responsibility, Labelling and Packaging Controls, and Supplier Controls, ensuring full regulatory coverage
  • Customisable implementation Work Plans (Word) with phased tasks, RACI assignments, deadlines, and milestone tracking to guide your team from gap analysis to full compliance deployment
  • 18 ready-to-deploy policy and procedure templates (Word) covering critical requirements including Design History File (DHF), Device Master Record (DMR), Device History Record (DHR), and Quality Audit Program, fully editable for rapid adoption
  • A benchmarking matrix (XLSX) comparing 21 CFR Part 820, ISO 13485, and EU MDR requirements, enabling global regulatory alignment and audit preparedness
  • 00_Platinum_Tier folder with 6 cornerstone files: a master Quality System Implementation Playbook (PDF), a 90-day compliance roadmap (XLSX), a CAPA case formulation template (PDF), an FDA inspection anti-pattern catalogue (XLSX), a Quality System Observability Dashboard (XLSX), and an Incident Response Runbook (PDF)
  • 01_Getting_Started: Immediate-start guide (PDF) for onboarding teams and initiating assessments within hours
  • 02_Self_Assessment_and_Diagnostics: Maturity assessments, compliance heatmaps, and gap-analysis worksheets (PDF and XLSX) to prioritise remediation
  • 03_Requirements_and_Goal_Setting: Stakeholder mapping tools, compliance objectives templates, and risk register models
  • 04_Models_and_Frameworks: Decision matrices for process design, framework comparisons, and best-practice implementation guides
  • 06_Processes_and_Execution: 15+ execution files including RACI templates, interview scripts for internal audits, and process validation worksheets
  • 07_Performance_and_KPIs: Pre-built dashboards (XLSX) tracking CAPA cycle times, audit findings, non-conformance rates, and process compliance trends
  • 08_Quality_and_Governance: Audit preparation checklists, policy review cycles, and FDA inspection readiness runbooks
  • 09_Sustainment_and_Improvement: Continuous improvement playbooks and feedback loops to maintain compliance long-term
  • 10_Advanced_Topics: Case archives and scenario libraries for high-risk classifications and complex device types
  • 11_Reference_and_Quick_Cards: At-a-glance reference guides for shop floor staff, QA leads, and regulatory reviewers
  • README.md and CUSTOMER_EMAIL.txt onboarding note providing immediate access instructions and file navigation

How This Helps You

This toolkit ensures you move from reactive compliance to proactive quality system management. With 999 validated assessment questions and 18 policy templates, you can conduct a full 21 CFR Part 820 gap analysis in under a week, pinpointing vulnerabilities before an FDA auditor does. The integrated Excel dashboards transform technical findings into executive insights, increasing board-level visibility and reducing time-to-remediation. Without this resource, organisations risk incomplete DHF documentation, inadequate CAPA workflows, and missed design control checkpoints, each a potential trigger for Form 483 observations or 510(k) refusal. By implementing this structured playbook, you future-proof your quality system, accelerate premarket submissions, and position your organisation as inspection-ready at all times.

Who Is This For?

  • Quality Assurance Managers responsible for maintaining FDA-compliant quality systems in medical device firms
  • Regulatory Affairs Specialists preparing for FDA inspections or 510(k) submissions
  • Quality System Auditors conducting internal or supplier audits under 21 CFR Part 820
  • Medical Device Project Managers leading new product development under design control requirements
  • QA Engineers and Compliance Leads implementing CAPA, document control, or production process validations
  • Operations Directors in contract manufacturers needing to demonstrate FDA-aligned quality processes to OEM partners

Choosing the 21 CFR Part 820 Toolkit isn’t just an investment in compliance, it’s a strategic decision to build a resilient, audit-ready quality system that supports faster regulatory clearance, stronger investor confidence, and sustained market access. This is the same framework used by leading medical device organisations to pass FDA audits with zero observations. Your next inspection starts today, make sure your documentation does too.